Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.
about
The potential impact of antifungal drug resistance mechanisms on the host immune response to CandidaComparison of echinocandin antifungalsDiscovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitorsSynergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformansEpidemiology of invasive candidiasis: a persistent public health problemDetermination of Echinocandin MICs for Candida species in less than 8 hours: comparison of the rapid susceptibility assay with the Clinical and Laboratory Standards Institute's broth microdilution assay.Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicansOropharyngeal candidiasis in the era of antiretroviral therapyMultiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditisCaspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcomeSpecific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.Antifungal susceptibility testing: practical aspects and current challenges.Regulatory circuitry governing fungal development, drug resistance, and disease.Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibilityIn vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.New methods to assess susceptibilities of Aspergillus isolates to caspofungin.Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance.Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsFurther standardization of broth microdilution methodology for in vitro susceptibility testing of caspofungin against Candida species by use of an international collection of more than 3,000 clinical isolates.Fungal infections: their diagnosis and treatment in transplant recipients.Increase of virulence and its phenotypic traits in drug-resistant strains of Candida albicans.Molecular analysis of CaMnt1p, a mannosyl transferase important for adhesion and virulence of Candida albicans.Anidulafungin in the treatment of invasive fungal infections.Resistance to echinocandin-class antifungal drugs.Treatment of candiduria with micafungin: A case series.Characterization of caspofungin susceptibilities by broth and agar in Candida albicans clinical isolates with characterized mechanisms of azole resistanceDevelopment of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistanceInterlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesChromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungalsChitinases in Pneumocystis carinii pneumoniaDecreased accumulation or increased isoleucyl-tRNA synthetase activity confers resistance to the cyclic beta-amino acid BAY 10-8888 in Candida albicans and Candida tropicalis.Optimization and validation of multilocus sequence typing for Candida albicans.Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans.Caspofungin activity against clinical isolates of fluconazole-resistant Candida.Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric Sensititre YeastOne mIn vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
P2860
Q27026751-29B73B44-F51E-474A-AD89-51EEE9DFB23DQ28273738-F8F0EA65-43CA-4D10-B1F1-70A9839527F8Q28343863-51846AC5-A8B4-4542-B523-61BA8652BCEDQ28343929-870B6AC8-DE61-4E06-8B08-08DBA63C9652Q29616758-897E7E7E-FCEE-4110-9AA8-DDF6E1C76198Q30435993-6A0E896D-D18D-4911-8CFD-4E731F2E4BA0Q31058690-77B66440-9C28-4B33-B227-330E766A96E2Q33695613-922DD613-5D08-4396-9EF0-0F0D7340A596Q33746435-6A305417-9FB3-4059-906D-9E358B5655C0Q33803108-9FFE3F70-F69D-46D8-AAD7-F5F7F1C7BB1EQ33935389-BD6DD2B8-5400-42C1-BCA0-A15F0ED8123BQ33938068-E42652AB-41A1-4B7B-A07C-89DE27F47618Q33975757-AFADD7A5-C9D2-4E21-9A86-D4B7D34C9A30Q34190284-6381CE7F-9BFE-402F-8AD8-3DFB0A68EF15Q34510707-2D03292D-BA92-4A7C-85F8-1EEEF159DA92Q34881309-9CF5BD55-A5AA-490A-BAA9-2F269F6172DAQ34956645-FA26BE7F-D554-44C5-B23C-959242A2D68DQ35129428-48FF95D4-EE96-4A21-9F4F-DCC3F0C9EF90Q35138937-2E23CD2B-D985-4CE7-9AF8-64C2F036211BQ35690629-EA5FADE8-CD76-40B7-B2BA-4EE916AFE1AAQ35718542-A2B8FF58-3A68-43F2-9FA4-B96ABEE77707Q36206568-A7F6F72A-2047-4AE1-A32C-58AFF0B6B95AQ36482736-CADE5E70-34BC-4A5B-988F-572E4270F6D1Q36504974-5FA0CDAC-2921-4564-AE3F-02AF13EA95E5Q36822941-C85E305F-C401-4CAC-8AD9-2BE21D686A96Q36849595-41A40D1F-A929-4595-A712-E68353008EE8Q36871028-3B6FF17B-375F-4AE3-A8EE-50B05D8BD30FQ36925967-B3F814A2-00F2-415B-9562-C70F186A76A4Q36933000-B285EDE3-94FD-414E-81B6-6FC4758EB084Q37122826-57B2E950-A0F7-411D-A8F7-3CC7B6110000Q37157546-E9CACB26-E0FF-44AC-92F8-B789C1D07AE3Q37263898-1970FC4D-12A8-4479-BF33-9DE07F0188A2Q37552773-CE73F8FE-AB43-4CA4-AF6D-C93D4B8AB251Q39557887-96FC2CAC-7376-4C49-888B-5A4C47FB6A32Q39848591-1236FBC5-2C15-48BE-94D6-66BA84F222CEQ40165193-A9A4795B-6F8A-4DEF-9D67-85815864246AQ40404311-AA5E83DB-5A51-4132-9CB5-676446153555Q41194660-FB2DAB87-1338-4455-9C9F-38A85E024FB9Q41640129-B0A4A15F-2768-407F-AF25-0EAF3BC9216DQ41810114-AB4A165E-FBE0-4600-A6A7-86FC6392535C
P2860
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Characterization of echinocand ...... emical, and virulence studies.
@ast
Characterization of echinocand ...... emical, and virulence studies.
@en
type
label
Characterization of echinocand ...... emical, and virulence studies.
@ast
Characterization of echinocand ...... emical, and virulence studies.
@en
prefLabel
Characterization of echinocand ...... emical, and virulence studies.
@ast
Characterization of echinocand ...... emical, and virulence studies.
@en
P2093
P2860
P1476
Characterization of echinocand ...... emical, and virulence studies.
@en
P2093
Bartizal K
Douglas CM
Flattery A
Marrinan JA
Milligan J
Nollstadt K
P2860
P304
P407
P577
1996-08-01T00:00:00Z